Realizing the Promise of Targeting TechnologiesEvery day, molecular targeting technologies are used to better diagnose and treat disease. Progress in genomic and proteomic research has led to significant developments in molecular targeting. These technologically advanced molecules target disease more selectively. When labeled with a radioisotope suitable for diagnostic imaging (either PET or SPECT), targeted molecules can offer improved sensitivity, leading to more accurate diagnosis of disease. For therapeutic applications, radiolabeled targeting molecules deliver highly localized radiation. As a result, smaller amounts of the drug are required meaning less toxicity, generally better quality of life for the patient and potentially improved efficacy. Learn more about how we can tailor our radiopharmaceutical services to your targeting molecule. To contact us click here. |
